Comment on the article: Successful therapy of Lyell's syndrome with intravenous immunoglobulins;Stellungnahme zum bericht: 'Erfolgreiche therapie des Lyell-syndroms mit intravenosen immunglobulinen'. ('Gehort - Gelesen - Nachgefragt') Hautarzt (1998) 49:950-951

Hautarzt

Volumn 50, Issue 7, 1999, Pages 513-514

  Mockenhaupt, Maja ^a   Schröder, Werner ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NOTE; TOXIC EPIDERMAL NECROLYSIS; IMMUNOLOGY; LETTER;

EPIDERMAL NECROLYSIS, TOXIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 0345517154     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050954     Document Type: Note

References (5)

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92
2. Mockenhaupt M, Schöpf E (1998) Epidemiology of severe cutaneous drug reactions. In: K Kauppinen et al. (eds) Skin reactions to drugs. CRC Press LLC, pp 3-15
3. Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, Holländer N, Bruppacher R, Schöpf E (1996) Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990-1992). Structure and results of a population based registry. J Clin Epidemiol 49:769-773
4. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockage of CD95 with human intravenous immunoglobulin. Science 282:490-493
5. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpier B, Pilorget A, Bocquet H, Brun-Buisson C, Revuz J (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352:1586-1589